Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00078026Phase 2Terminated
A Phase 2 trial of apomine in osteoporosis, osteopenia, sponsored by Sanofi. Started Aug 2003; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00078026.